These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1553371)

  • 21. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
    Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
    Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystectomy stimulates hypertrophy and hyperplasia in the hamster pancreas.
    Rosenberg L; Duguid WP; Brown RA
    J Surg Res; 1984 Aug; 37(2):108-11. PubMed ID: 6748630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrin does not stimulate growth of the rat pancreas.
    Chen D; Nylander AG; Norlén P; Håkanson R
    Scand J Gastroenterol; 1996 Apr; 31(4):404-10. PubMed ID: 8726311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous hypercholecystokininemia, but not aspirin, reduces the gallstone incidence in the hamster model.
    Borch K; Chu M; Kullman E; Carlsson B; Rehfeld JF
    Scand J Gastroenterol; 1994 Aug; 29(8):740-3. PubMed ID: 7973435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exocrine pancreatic nodules after longterm pancreaticobiliary diversion in rats. An effect of raised CCK plasma concentrations.
    Miazza BM; Widgren S; Chayvialle JA; Nicolet T; Loizeau E
    Gut; 1987; 28 Suppl(Suppl):269-73. PubMed ID: 3692317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
    Howatson AG; Carter DC
    Br J Cancer; 1985 Jan; 51(1):107-14. PubMed ID: 3966964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin octapeptide induces both proliferation and apoptosis in the rat pancreas.
    Trulsson LM; Svanvik J; Permert J; Gasslander T
    Regul Pept; 2001 Apr; 98(1-2):41-8. PubMed ID: 11179777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gastric fundusectomy and antrectomy on gallbladder epithelial proliferation in the hamster.
    Chu M; Rehfeld JF; Borch K
    Surgery; 1994 Feb; 115(2):222-6. PubMed ID: 8310411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster.
    Herrington MK; Gasslander T; Cina RA; Fehsenfeld DM; Kazakoff KR; Pour PM; Adrian TE
    Nutr Cancer; 1997; 28(3):219-24. PubMed ID: 9343829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin is not a major determinant for the changes in beta-cell function seen after pancreatico-biliary diversion in rats.
    Gasslander T; Lilja I; Smeds S; Lundquist I; Ihse I
    Diabetes Res; 1991 Nov; 18(3):135-42. PubMed ID: 1841824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trophic effect of caerulein on the normal pancreas and enhancement in experimental pancreatic cancer by caerulein in the Syrian golden hamster].
    Mukai R
    Nihon Geka Gakkai Zasshi; 1985 May; 86(5):602-12. PubMed ID: 4021992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory effects on the pancreas of intraduodenal pancreatic juice and trypsin in the Syrian golden hamster.
    Andrén-Sandberg A; Ihse I
    Scand J Gastroenterol; 1983 Jul; 18(5):697-706. PubMed ID: 6201995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Zucker KA; Bilchik AJ; Pour PM; Adrian TE
    Cancer Lett; 1994 Jul; 82(1):7-16. PubMed ID: 8033071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex-vivo isolated perfusion of the pancreas in the Syrian golden hamster.
    Bell RH; Place S; McCullough P; Ray MB; Rogers DH
    Int J Pancreatol; 1986 May; 1(1):71-81. PubMed ID: 3693978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.